Epilepsy Market Size and Forecasts, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Route of Administration, Treatment Type, Age Group, Distribution Channel, and Geography

List of Tables

The epilepsy market size is expected to grow from US$ 7.7 billion in 2022 to US$ 10.7 billion by 2030; it is projected to register a CAGR of 4.1% during 2022-2030.

Epilepsy is one of the most common chronic neurological disorders across the world. Associated with an abnormal electrical activity in the brain, this disorder affects over 1 million American women of childbearing age. The rising prevalence of epilepsy and increasing investments in the development of epilepsy therapies are noteworthy factors contributing to the expansion of the epilepsy market size. The administration of anti-epileptic drugs (AEDs) is usually referred to as the first-line treatment for epilepsy. Approximately 80% of the people suffering from epilepsy are from developing countries. In children as well as adults, the treatment of epilepsy is mostly based on the use of drugs (either in monotherapy or combined therapy), while the remaining treatment approaches, such as surgery, neuromodulation, and ketogenic diet, are used at a lesser frequency. However, the recall of products hinders the epilepsy market growth.

Age Group-Based Insights

Based on age group, the epilepsy market is segmented into adults and children. The adults segment held a larger epilepsy market share in 2022. It is further expected to register a higher CAGR in the market during 2022-2030. Epilepsy is more likely to develop in adults as some risk factors for this disease are more common in adults; these include diseases affecting brain function (such as Alzheimer's disease), brain tumors, strokes, and head injuries. According to the Centers for Disease Control and Prevention (CDC), 3 million adults aged 18 or older are living with active epilepsy in the US. Nearly 1 million of these adults are aged 55 or older. As the population ages, even more older people are likely to suffer from epilepsy in the coming years. In 2021, 1.1% of US adults (~2.86 million adults) reported active epilepsy. Thus, medications and treatment strategies often prioritize adult patients, aligning with the demographic prevalence of epilepsy in this age group.

End User-Based Insights

Based on distribution channel, the epilepsy market is segmented into hospital pharmacies, retail pharmacies, and others. The hospital pharmacies segment held the largest epilepsy market share in 2022. In addition, the retail pharmacies segment is expected to register the highest CAGR in the market during 2022-2030. Retail pharmacy stores sell prescription drugs, over-the-counter drugs, and some fast-moving consumer goods, along with providing related services. Modern retail pharmacy chains are digitized, organized, and tech-enabled, which allows them to track medication inventories and sell 100% reliable goods. In addition, retail pharmacy chains provide value-added services for consumers opting for medical claims or insurance filings. They can also be requested to refurbish previous bills or memos. Moreover, their locations make them accessible for patients to fill their prescriptions and receive counseling from pharmacists.

Centers for Disease Control and Prevention, the World Health Organization, and Neurological Health Charities Canada are among the primary and secondary sources referred to while preparing the epilepsy market report.

Product Code: TIPRE00016405

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Epilepsy Market Landscape

4.1 Overview
4.2 PEST Analysis

5. Epilepsy Market - Key Market Dynamics

5.1 Epilepsy Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Rising Prevalence of Epilepsy
- 5.2.2 Increasing Investments in Development of Epilepsy Therapies
5.3 Market Restraints
- 5.3.1 Recall of Products
5.4 Market Opportunities
- 5.4.1 Surge in Awareness Programs Conducted by Organizations
5.5 Future Trends
- 5.5.1 Gene Therapy as Promising Treatment Approach
5.6 Impact of Drivers and Restraints:

6. Epilepsy Market - Global Market Analysis

6.1 Epilepsy Market Revenue (US$ Million), 2022-2030

7. Epilepsy Market Analysis - by Type

7.1 Overview
7.2 Progressive Myoclonic Epilepsy
- 7.2.1 Overview
- 7.2.2 Progressive Myoclonic Epilepsy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Reflex Epilepsy
- 7.3.1 Overview
- 7.3.2 Reflex Epilepsy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Generalized Epilepsy
- 7.4.1 Overview
- 7.4.2 Generalized Epilepsy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Other
- 7.5.1 Overview
- 7.5.2 Other: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

8. Epilepsy Market Analysis - by Route of Administration

8.1 Overview
8.2 Oral
- 8.2.1 Overview
- 8.2.2 Oral: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Parenteral
- 8.3.1 Overview
- 8.3.2 Parenteral: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Others
- 8.4.1 Overview
- 8.4.2 Others: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

9. Epilepsy Market Analysis - by Treatment Type

9.1 Overview
9.2 First Generation Drugs
- 9.2.1 Overview
- 9.2.2 First Generation Drugs: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Second Generation Drugs
- 9.3.1 Overview
- 9.3.2 Second Generation Drugs: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Third Generation Drugs
- 9.4.1 Overview
- 9.4.2 Third Generation Drugs: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

10. Epilepsy Market Analysis - by Age Group

10.1 Overview
10.2 Adult
- 10.2.1 Overview
- 10.2.2 Adult: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
10.3 Children
- 10.3.1 Overview
- 10.3.2 Children: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

11. Epilepsy Market Analysis - by Distribution Channel

11.1 Overview
11.2 Hospital Pharmacies
- 11.2.1 Overview
- 11.2.2 Hospital Pharmacies: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
11.3 Retail Pharmacies
- 11.3.1 Overview
- 11.3.2 Retail Pharmacies: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
11.4 Others
- 11.4.1 Overview
- 11.4.2 Others: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

12. Epilepsy Market - Geographical Analysis

12.1 North America: Epilepsy Market
- 12.1.1 Overview
- 12.1.2 North America: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
  - 12.1.2.1 North America: Epilepsy Market - Revenue and Forecast Analysis - by Type
  - 12.1.2.2 North America: Epilepsy Market - Revenue and Forecast Analysis - by Route of Administration
  - 12.1.2.3 North America: Epilepsy Market - Revenue and Forecast Analysis - by Treatment Type
  - 12.1.2.4 North America: Epilepsy Market - Revenue and Forecast Analysis - by Age Group
  - 12.1.2.5 North America: Epilepsy Market - Revenue and Forecast Analysis - by Distribution Channel
- 12.1.3 North America: Epilepsy Market - Revenue and Forecast Analysis - by Country
  - 12.1.3.1 United States: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.1.3.1.1 Overview
    - 12.1.3.1.2 United States: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.1.3.1.3 United States: Epilepsy Market Breakdown, by Type
    - 12.1.3.1.4 United States: Epilepsy Market Breakdown, by Route of Administration
    - 12.1.3.1.5 United States: Epilepsy Market Breakdown, by Treatment Type
    - 12.1.3.1.6 United States: Epilepsy Market Breakdown, by Age Group
    - 12.1.3.1.7 United States: Epilepsy Market Breakdown, by Distribution Channel
  - 12.1.3.2 Canada: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.1.3.2.1 Overview
  - 12.1.3.3 Canada: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.1.3.3.1 Canada: Epilepsy Market Breakdown, by Type
    - 12.1.3.3.2 Canada: Epilepsy Market Breakdown, by Route of Administration
    - 12.1.3.3.3 Canada: Epilepsy Market Breakdown, by Treatment Type
    - 12.1.3.3.4 Canada: Epilepsy Market Breakdown, by Age Group
    - 12.1.3.3.5 Canada: Epilepsy Market Breakdown, by Distribution Channel
  - 12.1.3.4 Mexico: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.1.3.4.1 Overview
  - 12.1.3.5 Mexico: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.1.3.5.1 Mexico: Epilepsy Market Breakdown, by Type
    - 12.1.3.5.2 Mexico: Epilepsy Market Breakdown, by Route of Administration
    - 12.1.3.5.3 Mexico: Epilepsy Market Breakdown, by Treatment Type
    - 12.1.3.5.4 Mexico: Epilepsy Market Breakdown, by Age Group
    - 12.1.3.5.5 Mexico: Epilepsy Market Breakdown, by Distribution Channel
12.2 Europe: Epilepsy Market
- 12.2.1 Overview
- 12.2.2 Europe: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
  - 12.2.2.1 Europe: Epilepsy Market - Revenue and Forecast Analysis - by Type
  - 12.2.2.2 Europe: Epilepsy Market - Revenue and Forecast Analysis - by Route of Administration
  - 12.2.2.3 Europe: Epilepsy Market - Revenue and Forecast Analysis - by Treatment Type
  - 12.2.2.4 Europe: Epilepsy Market - Revenue and Forecast Analysis - by Age Group
  - 12.2.2.5 Europe: Epilepsy Market - Revenue and Forecast Analysis - by Distribution Channel
- 12.2.3 Europe: Epilepsy Market - Revenue and Forecast Analysis - by Country
  - 12.2.3.1 United Kingdom: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.2.3.1.1 Overview
  - 12.2.3.2 United Kingdom: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.2.3.2.1 United Kingdom: Epilepsy Market Breakdown, by Type
    - 12.2.3.2.2 United Kingdom: Epilepsy Market Breakdown, by Route of Administration
    - 12.2.3.2.3 United Kingdom: Epilepsy Market Breakdown, by Treatment Type
    - 12.2.3.2.4 United Kingdom: Epilepsy Market Breakdown, by Age Group
    - 12.2.3.2.5 United Kingdom: Epilepsy Market Breakdown, by Distribution Channel
  - 12.2.3.3 Germany: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.2.3.3.1 Overview
  - 12.2.3.4 Germany: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.2.3.4.1 Germany: Epilepsy Market Breakdown, by Type
    - 12.2.3.4.2 Germany: Epilepsy Market Breakdown, by Route of Administration
    - 12.2.3.4.3 Germany: Epilepsy Market Breakdown, by Treatment Type
    - 12.2.3.4.4 Germany: Epilepsy Market Breakdown, by Age Group
    - 12.2.3.4.5 Germany: Epilepsy Market Breakdown, by Distribution Channel
  - 12.2.3.5 France: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.2.3.5.1 Overview
  - 12.2.3.6 France: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.2.3.6.1 France: Epilepsy Market Breakdown, by Type
    - 12.2.3.6.2 France: Epilepsy Market Breakdown, by Route of Administration
    - 12.2.3.6.3 France: Epilepsy Market Breakdown, by Treatment Type
    - 12.2.3.6.4 France: Epilepsy Market Breakdown, by Age Group
    - 12.2.3.6.5 France: Epilepsy Market Breakdown, by Distribution Channel
  - 12.2.3.7 Spain: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.2.3.7.1 Overview
  - 12.2.3.8 Spain: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.2.3.8.1 Spain: Epilepsy Market Breakdown, by Type
    - 12.2.3.8.2 Spain: Epilepsy Market Breakdown, by Route of Administration
    - 12.2.3.8.3 Spain: Epilepsy Market Breakdown, by Treatment Type
    - 12.2.3.8.4 Spain: Epilepsy Market Breakdown, by Age Group
    - 12.2.3.8.5 Spain: Epilepsy Market Breakdown, by Distribution Channel
  - 12.2.3.9 Italy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.2.3.9.1 Overview
  - 12.2.3.10 Italy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.2.3.10.1 Italy: Epilepsy Market Breakdown, by Type
    - 12.2.3.10.2 Italy: Epilepsy Market Breakdown, by Route of Administration
    - 12.2.3.10.3 Italy: Epilepsy Market Breakdown, by Treatment Type
    - 12.2.3.10.4 Italy: Epilepsy Market Breakdown, by Age Group
    - 12.2.3.10.5 Italy: Epilepsy Market Breakdown, by Distribution Channel
  - 12.2.3.11 Rest of Europe: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.2.3.11.1 Overview
  - 12.2.3.12 Rest of Europe: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.2.3.12.1 Rest of Europe: Epilepsy Market Breakdown, by Type
    - 12.2.3.12.2 Rest of Europe: Epilepsy Market Breakdown, by Route of Administration
    - 12.2.3.12.3 Rest of Europe: Epilepsy Market Breakdown, by Treatment Type
    - 12.2.3.12.4 Rest of Europe: Epilepsy Market Breakdown, by Age Group
    - 12.2.3.12.5 Rest of Europe: Epilepsy Market Breakdown, by Distribution Channel
12.3 Asia Pacific: Epilepsy Market
- 12.3.1 Overview
- 12.3.2 Asia Pacific: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
  - 12.3.2.1 Asia Pacific: Epilepsy Market - Revenue and Forecast Analysis - by Type
  - 12.3.2.2 Asia Pacific: Epilepsy Market - Revenue and Forecast Analysis - by Route of Administration
  - 12.3.2.3 Asia Pacific: Epilepsy Market - Revenue and Forecast Analysis - by Treatment Type
  - 12.3.2.4 Asia Pacific: Epilepsy Market - Revenue and Forecast Analysis - by Age Group
  - 12.3.2.5 Asia Pacific: Epilepsy Market - Revenue and Forecast Analysis - by Distribution Channel
- 12.3.3 Asia Pacific: Epilepsy Market - Revenue and Forecast Analysis - by Country
  - 12.3.3.1 China: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.3.3.1.1 Overview
  - 12.3.3.2 China: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.3.3.2.1 China: Epilepsy Market Breakdown, by Type
    - 12.3.3.2.2 China: Epilepsy Market Breakdown, by Route of Administration
    - 12.3.3.2.3 China: Epilepsy Market Breakdown, by Treatment Type
    - 12.3.3.2.4 China: Epilepsy Market Breakdown, by Age Group
    - 12.3.3.2.5 China: Epilepsy Market Breakdown, by Distribution Channel
  - 12.3.3.3 Japan: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.3.3.3.1 Overview
  - 12.3.3.4 Japan: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.3.3.4.1 Japan: Epilepsy Market Breakdown, by Type
    - 12.3.3.4.2 Japan: Epilepsy Market Breakdown, by Route of Administration
    - 12.3.3.4.3 Japan: Epilepsy Market Breakdown, by Treatment Type
    - 12.3.3.4.4 Japan: Epilepsy Market Breakdown, by Age Group
    - 12.3.3.4.5 Japan: Epilepsy Market Breakdown, by Distribution Channel
  - 12.3.3.5 India: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.3.3.5.1 Overview
  - 12.3.3.6 India: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.3.3.6.1 India: Epilepsy Market Breakdown, by Type
    - 12.3.3.6.2 India: Epilepsy Market Breakdown, by Route of Administration
    - 12.3.3.6.3 India: Epilepsy Market Breakdown, by Treatment Type
    - 12.3.3.6.4 India: Epilepsy Market Breakdown, by Age Group
    - 12.3.3.6.5 India: Epilepsy Market Breakdown, by Distribution Channel
  - 12.3.3.7 Australia: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.3.3.7.1 Overview
  - 12.3.3.8 Australia: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.3.3.8.1 Australia: Epilepsy Market Breakdown, by Type
    - 12.3.3.8.2 Australia: Epilepsy Market Breakdown, by Route of Administration
    - 12.3.3.8.3 Australia: Epilepsy Market Breakdown, by Treatment Type
    - 12.3.3.8.4 Australia: Epilepsy Market Breakdown, by Age Group
    - 12.3.3.8.5 Australia: Epilepsy Market Breakdown, by Distribution Channel
  - 12.3.3.9 South Korea: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.3.3.9.1 Overview
  - 12.3.3.10 South Korea: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.3.3.10.1 South Korea: Epilepsy Market Breakdown, by Type
    - 12.3.3.10.2 South Korea: Epilepsy Market Breakdown, by Route of Administration
    - 12.3.3.10.3 South Korea: Epilepsy Market Breakdown, by Treatment Type
    - 12.3.3.10.4 South Korea: Epilepsy Market Breakdown, by Age Group
    - 12.3.3.10.5 South Korea: Epilepsy Market Breakdown, by Distribution Channel
  - 12.3.3.11 Rest of Asia Pacific: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.3.3.11.1 Overview
  - 12.3.3.12 Rest of APAC: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.3.3.12.1 Rest of APAC: Epilepsy Market Breakdown, by Type
    - 12.3.3.12.2 Rest of APAC: Epilepsy Market Breakdown, by Route of Administration
    - 12.3.3.12.3 Rest of APAC: Epilepsy Market Breakdown, by Treatment Type
    - 12.3.3.12.4 Rest of APAC: Epilepsy Market Breakdown, by Age Group
    - 12.3.3.12.5 Rest of APAC: Epilepsy Market Breakdown, by Distribution Channel
12.4 Middle East & Africa Epilepsy Market
- 12.4.1 Overview
- 12.4.2 Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
  - 12.4.2.1 Middle East and Africa: Epilepsy Market - Revenue and Forecast Analysis - by Type
  - 12.4.2.2 Middle East and Africa: Epilepsy Market - Revenue and Forecast Analysis - by Route of Administration
  - 12.4.2.3 Middle East and Africa: Epilepsy Market - Revenue and Forecast Analysis - by Treatment Type
  - 12.4.2.4 Middle East and Africa: Epilepsy Market - Revenue and Forecast Analysis - by Age Group
  - 12.4.2.5 Middle East and Africa: Epilepsy Market - Revenue and Forecast Analysis - by Distribution Channel
- 12.4.3 Middle East and Africa: Epilepsy Market - Revenue and Forecast Analysis - by Country
  - 12.4.3.1 Saudi Arabia: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.4.3.1.1 Overview
  - 12.4.3.2 Saudi Arabia: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.4.3.2.1 Saudi Arabia: Epilepsy Market Breakdown, by Type
    - 12.4.3.2.2 Saudi Arabia: Epilepsy Market Breakdown, by Route of Administration
    - 12.4.3.2.3 Saudi Arabia: Epilepsy Market Breakdown, by Treatment Type
    - 12.4.3.2.4 Saudi Arabia: Epilepsy Market Breakdown, by Age Group
    - 12.4.3.2.5 Saudi Arabia: Epilepsy Market Breakdown, by Distribution Channel
  - 12.4.3.3 South Africa: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.4.3.3.1 Overview
  - 12.4.3.4 South Africa: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.4.3.4.1 South Africa: Epilepsy Market Breakdown, by Type
    - 12.4.3.4.2 South Africa: Epilepsy Market Breakdown, by Route of Administration
    - 12.4.3.4.3 South Africa: Epilepsy Market Breakdown, by Treatment Type
    - 12.4.3.4.4 South Africa: Epilepsy Market Breakdown, by Age Group
    - 12.4.3.4.5 South Africa: Epilepsy Market Breakdown, by Distribution Channel
  - 12.4.3.5 United Arab Emirates: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.4.3.5.1 Overview
  - 12.4.3.6 United Arab Emirates: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.4.3.6.1 United Arab Emirates: Epilepsy Market Breakdown, by Type
    - 12.4.3.6.2 United Arab Emirates: Epilepsy Market Breakdown, by Route of Administration
    - 12.4.3.6.3 United Arab Emirates: Epilepsy Market Breakdown, by Treatment Type
    - 12.4.3.6.4 United Arab Emirates: Epilepsy Market Breakdown, by Age Group
    - 12.4.3.6.5 United Arab Emirates: Epilepsy Market Breakdown, by Distribution Channel
  - 12.4.3.7 Rest of Middle East & Africa: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.4.3.7.1 Overview
  - 12.4.3.8 Rest of Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.4.3.8.1 Rest of Middle East and Africa: Epilepsy Market Breakdown, by Type
    - 12.4.3.8.2 Rest of Middle East and Africa: Epilepsy Market Breakdown, by Route of Administration
    - 12.4.3.8.3 Rest of Middle East and Africa: Epilepsy Market Breakdown, by Treatment Type
    - 12.4.3.8.4 Rest of Middle East and Africa: Epilepsy Market Breakdown, by Age Group
    - 12.4.3.8.5 Rest of Middle East and Africa: Epilepsy Market Breakdown, by Distribution Channel
12.5 South & Central America: Epilepsy Market
- 12.5.1 Overview
- 12.5.2 South and Central America: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
  - 12.5.2.1 South and Central America: Epilepsy Market - Revenue and Forecast Analysis - by Type
  - 12.5.2.2 South and Central America: Epilepsy Market - Revenue and Forecast Analysis - by Route of Administration
  - 12.5.2.3 South and Central America: Epilepsy Market - Revenue and Forecast Analysis - by Treatment Type
  - 12.5.2.4 South and Central America: Epilepsy Market - Revenue and Forecast Analysis - by Age Group
  - 12.5.2.5 South and Central America: Epilepsy Market - Revenue and Forecast Analysis - by Distribution Channel
- 12.5.3 South and Central America: Epilepsy Market - Revenue and Forecast Analysis - by Country
  - 12.5.3.1 Brazil: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.5.3.1.1 Overview
  - 12.5.3.2 Brazil: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.5.3.2.1 Brazil: Epilepsy Market Breakdown, by Type
    - 12.5.3.2.2 Brazil: Epilepsy Market Breakdown, by Route of Administration
    - 12.5.3.2.3 Brazil: Epilepsy Market Breakdown, by Treatment Type
    - 12.5.3.2.4 Brazil: Epilepsy Market Breakdown, by Age Group
    - 12.5.3.2.5 Brazil: Epilepsy Market Breakdown, by Distribution Channel
  - 12.5.3.3 Argentina: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.5.3.3.1 Overview
  - 12.5.3.4 Argentina: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.5.3.4.1 Argentina: Epilepsy Market Breakdown, by Type
    - 12.5.3.4.2 Argentina: Epilepsy Market Breakdown, by Route of Administration
    - 12.5.3.4.3 Argentina: Epilepsy Market Breakdown, by Treatment Type
    - 12.5.3.4.4 Argentina: Epilepsy Market Breakdown, by Age Group
    - 12.5.3.4.5 Argentina: Epilepsy Market Breakdown, by Distribution Channel
  - 12.5.3.5 Rest of South & Central America: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.5.3.5.1 Overview
  - 12.5.3.6 Rest of South and Central America: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.5.3.6.1 Rest of South and Central America: Epilepsy Market Breakdown, by Type
    - 12.5.3.6.2 Rest of South and Central America: Epilepsy Market Breakdown, by Route of Administration
    - 12.5.3.6.3 Rest of South and Central America: Epilepsy Market Breakdown, by Treatment Type
    - 12.5.3.6.4 Rest of South and Central America: Epilepsy Market Breakdown, by Age Group
    - 12.5.3.6.5 Rest of South and Central America: Epilepsy Market Breakdown, by Distribution Channel

13. Industry Landscape

13.1 Overview
13.2 Growth Strategies in Epilepsy Market
13.3 Organic Growth Strategies
- 13.3.1 Overview
13.4 Inorganic Growth Strategies
- 13.4.1 Overview

14. Company Profiles

14.1 Abbott Laboratories
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Pfizer Inc
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Eisai Co Ltd
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 UCB SA
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 CombiGene AB
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 LivaNova Plc
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Novartis AG
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Medtronic Plc
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 GSK Plc
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 H. Lundbeck AS
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments

15. Appendix

15.1 About The Insight Partners